A new trading day began on Friday, with Mustang Bio Inc (NASDAQ: MBIO) stock price down -3.14% from the previous day of trading, before settling in for the closing price of $0.24. MBIO’s price has ranged from $0.13 to $1.73 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 86.50%. With a float of $33.65 million, this company’s outstanding shares have now reached $37.23 million.
In an organization with 80 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 52.85%, operating margin of -835.67%, and the pretax margin is -812.49%.
Mustang Bio Inc (MBIO) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Mustang Bio Inc is 9.62%, while institutional ownership is 2.49%.
Mustang Bio Inc (MBIO) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.71 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.61 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 86.50% per share during the next fiscal year.
Mustang Bio Inc (NASDAQ: MBIO) Trading Performance Indicators
Here are Mustang Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.79, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of Mustang Bio Inc (MBIO)
Let’s dig in a bit further. During the last 5-days, its volume was 1.11 million. That was inferior than the volume of 9.11 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 26.30%. Additionally, its Average True Range was 0.03.
During the past 100 days, Mustang Bio Inc’s (MBIO) raw stochastic average was set at 4.77%, which indicates a significant decrease from 12.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.16% in the past 14 days, which was lower than the 100.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2477, while its 200-day Moving Average is $0.5043. However, in the short run, Mustang Bio Inc’s stock first resistance to watch stands at $0.2418. Second resistance stands at $0.2554. The third major resistance level sits at $0.2707. If the price goes on to break the first support level at $0.2129, it is likely to go to the next support level at $0.1976. Assuming the price breaks the second support level, the third support level stands at $0.1840.
Mustang Bio Inc (NASDAQ: MBIO) Key Stats
With a market capitalization of 10.57 million, the company has a total of 37,233K Shares Outstanding. Currently, annual sales are 0 K while annual income is -51,600 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,410 K.
